These findings establish skin as a robust and accessible site of pre-symptomatic TDP-43 pathology, supporting its potential as a minimally invasive biomarker for early diagnosis and disease stratification in ALS. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.